REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
8 hedge funds and large institutions have $3.37M invested in REVIVA PHARMA HLDGS INC in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
167% more funds holding
Funds holding: 3 → 8 (+5)
7% more capital invested
Capital invested by funds: $3.15M → $3.37M (+$216K)
0.12% more ownership
Funds ownership: 0.2% → 0.32% (+0.12%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
EMC Capital Management
Houston,
Texas
|
+$633K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$502K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$306K |
| 4 |
Millennium Management
New York
|
+$295K |
| 5 |
DC
Davenport & Co
Richmond,
Virginia
|
+$125K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $2.4M | +$502K | +3,007 | +17% |
|
|
ECM
2
EMC Capital Management
Houston,
Texas
| $435K | +$633K | +3,792 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $210K | +$306K | +1,833 | New |
|
|
4
Millennium Management
New York
| $203K | +$295K | +1,766 | New |
|
|
DC
5
Davenport & Co
Richmond,
Virginia
| $86K | +$125K | +750 | New |
|
|
WAM
6
Wolverine Asset Management
Chicago,
Illinois
| $17K | +$25.7K | +154 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $12K | +$16.8K | +101 | +3,367% |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$15K | -86 | Closed |
|
9
Wells Fargo
San Francisco,
California
| – | +$334 | +2 | New |
|
RVPH Hedge Fund Activity: Q1 2021 in Review
8 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q1 2021, worth a combined $3.37M — up 6.9% from $3.15M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new RVPH positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was EMC Capital Management, opening a new position worth an estimated $633K. The largest seller was UBS Group, exiting entirely with an estimated $15K sold.
- 8 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q1 2021, up from 3 in Q4 2020.
- Funds reported $3.37M of REVIVA PHARMA HLDGS INC stock for Q1 2021, up 6.9% quarter-over-quarter.
- 6 funds opened new REVIVA PHARMA HLDGS INC positions in Q1 2021 and 1 closed out, a net change of +5 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q1 2021 was EMC Capital Management, an estimated $633K added.
- The largest REVIVA PHARMA HLDGS INC seller in Q1 2021 was UBS Group, an estimated $15K sold.
Based on aggregated 13F filings for Q1 2021.